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Abstract
Muscle satellite cells make up a stem cell population that is capable of differentiating into myocytes and contributing to
muscle regeneration upon injury. In this work we investigate the mechanism by which these muscle progenitor cells adopt
an alternative cell fate, the cartilage fate. We show that chick muscle satellite cells that normally would undergo myogenesis
can be converted to express cartilage matrix proteins in vitro when cultured in chondrogenic medium containing TGFß3 or
BMP2. In the meantime, the myogenic program is repressed, suggesting that muscle satellite cells have undergone
chondrogenic differentiation. Furthermore, ectopic expression of the myogenic factor Pax3 prevents chondrogenesis in
these cells, while chondrogenic factors Nkx3.2 and Sox9 act downstream of TGFß or BMP2 to promote this cell fate
transition. We found that Nkx3.2 and Sox9 repress the activity of the Pax3 promoter and that Nkx3.2 acts as a transcriptional
repressor in this process. Importantly, a reverse function mutant of Nkx3.2 blocks the ability of Sox9 to both inhibit
myogenesis and induce chondrogenesis, suggesting that Nkx3.2 is required for Sox9 to promote chondrogenic
differentiation in satellite cells. Finally, we found that in an in vivo mouse model of fracture healing where muscle progenitor
cells were lineage-traced, Nkx3.2 and Sox9 are significantly upregulated while Pax3 is significantly downregulated in the
muscle progenitor cells that give rise to chondrocytes during fracture repair. Thus our in vitro and in vivo analyses suggest
that the balance of Pax3, Nkx3.2 and Sox9 may act as a molecular switch during the chondrogenic differentiation of muscle
progenitor cells, which may be important for fracture healing.
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Introduction
Satellite cells are the tissue specific stem cells in the adult skeletal
muscle. These cells lie beneath the basement membrane of the
muscle fiber and are usually mitotically quiescent [1]. Upon injury
or when challenged with a variety of mechanical or biochemical
stimuli, satellite cells re-enter the cell cycle and give rise to
differentiated myocytes, which form new muscle fibers or fuse with
existing fibers, and contribute to muscle growth and repair [1].
Satellite cells from the trunk and the limb are derived from an
embryonic population of progenitor cells in the somites, transient
mesodermal structures that develop on either side of the neural
tube [1]. These embryonic progenitor cells are characterized by
the expression of transcription factors Pax3 and Pax7, which are
important for muscle differentiation and survival [2] and for
specifying the muscle satellite cell population responsible for
postnatal growth [1,3]. Upon activation, satellite cells rapidly
initiate MyoD expression, which leads to the activation of
myogenin, and terminally differentiated structural muscle genes
such as myosin heavy chain (MHC) [1,3]. Interestingly, recent
data indicated that although MyoD is not expressed in quiescent
satellite cells in the adult, it is transiently expressed in satellite cell
progenitors in the embryo, suggesting that satellite cells are derived
from committed embryonic precursors of myogenic lineage [4,5].
Initially, satellite cells were considered to be unipotent stem cells
with the ability of generating a unique specialized phenotype, the
skeletal muscle cells. However, satellite cells have since been shown
to have the ability to adopt alternative cell fates. One such
alternative cell fate is the adipogenic fate, as Pax7(+) satellite cells
isolated from single myofibers adopted adipogenic fate, in addition
to muscle fate in vitro [6,7]. Another alternative cell fate is the
osteogenic fate, as muscle satellite cells have been shown to be
induced by BMPs to differentiate into osteoblasts in culture
[7,8,9,10].
PLoS ONE | www.plosone.org 1 July 2012 | Volume 7 | Issue 7 | e39642Satellite cells have also been shown to have the capacity to form
cartilage. In vivo, Pax7(+) satellite cells were found to contribute to
cartilage growth in salamanders during limb regeneration after
amputation [7,11]. Furthermore, lineage-labeled satellite cells
were found to express cartilage marker collagen II in a mouse
model of fracture healing [12–13]. Such satellite cells accumulate
in the callus tissue of the fracture site, exhibit the typical
morphology of chondrocytes and participate in cartilage forma-
tion, which is an essential step in fracture healing [14,15]. In fact,
when a physical barrier (a cell impermeable membrane) was
introduced between the muscle and fractured bone, subsequent
fracture healing was significantly impaired [16]. Consistently,
when isolated muscle was infected with BMP2, it served as a
superior bridge for fracture repair [17]. In vitro, L6 myoblasts and
C2C12 myoblasts were reported to differentiate into chondrocytes
when treated with demineralized bone matrix or BMP2
[18,19,20,21]. These observations suggest that muscle satellite
cells or myoblasts can undergo chondrogenic differentiation, and
that this process may play an important role in cartilage and
regeneration during fracture healing. However, the molecular
mechanisms by which muscle satellite cells adopt a cartilage fate
still remain elusive. While TGFß/BMP signaling has been shown
to be important in this process, very little is known about how
downstream intracellular factors regulate cell fate transition in
muscle progenitor cells.
In this work, we have characterized the molecular events that
lead to the adoption of cartilage cell fate in muscle satellite cells.
We demonstrate that two transcription factors, Nkx3.2 and Sox9,
act downstream of TGFß/BMP signaling to regulate the transition
from myogenic fate to a chondrogenic fate. Nkx3.2 and Sox9 were
both found to promote chondrogenesis in the satellite cells, but
Nkx3.2 strongly inhibits the adoption of muscle cell fate while
Sox9 only weakly inhibits myogenesis in satellite cells. A reverse
function mutant of Nkx3.2 blocks the activity of Sox9, suggesting
that Nkx3.2 is required for Sox9 to promote cartilage formation in
satellite cells. In addition, we found that the muscle-determining
factor Pax3 strongly inhibits chondrogenesis. To explore the in vivo
significance of these factors, we used a mouse fracture healing
model in a genetically modified reporter mouse where muscle
progenitors were lineage-traced. We found that in the descendents
of muscle progenitors that contributed to cartilage formation,
Nkx3.2 and Sox9 were strongly induced, while Pax3 expression
was strongly repressed. Together, our data suggest that the
balance of Nkx3.2, Sox9 and Pax3 can act as a molecular switch
during the chondrogenic differentiation of satellite cells, which
may play an important role in the healing process in vivo.
Materials and Methods
Satellite Cell Isolation
Chicken eggs were purchased from Hy-line Inc., Pennsylvania.
Satellite cells were isolated from day 17 chicken pre-hatch
embryos according to an established protocol [22]. Briefly,
pectoral muscles were dissected and placed into sterile PBS with
penicillin/streptomycin and then minced. Ground muscle was
placed in a centrifuge tube and digested with pronase (1 mg/ml in
PBS) in a 37uC water bath for 40 min, with agitation every
10 min. The tube was centrifuged for 4 min at 3000 rpm. The
supernatant was then discarded, and the pellet was resuspended
with PBS and vortexed briefly. The tube was then centrifuged for
10 min at 1000 rpm three times, and the satellite cell-containing
supernatants from each cycle were saved and pooled into a new
sterile 50 ml centrifuge tube. The supernatants were then passed
through a 40 mM cell strainer (BD Biosciences, San Jose, CA) to
obtain a single cell suspension, centrifuged for 6 minutes at
3000 rpm and the resulting supernatants were discarded. The cell
pellet was resuspended in medium: DMEM (Invitrogen, CA), 10%
FBS (Hyclone, IL) and 1% penicillin/streptomycin (Invitrogen);
and then cells were plated on tissue culture plates. Plates were
incubated for 24 hours in a humidified 37uC, 5% CO2 incubator,
and then washed with sterile PBS to remove non-adherent cells.
All freshly isolated cells were confirmed to be positive for satellite
cell specific markers, Pax3 and Pax7, before subsequent experi-
ments were conducted.
Cell Culture
Satellite cells were cultured in DMEM with 10% FBS (Hyclone,
Logan, UT) and 1% antibiotic/mycotic (Invitrogen, CA). For
chondrogenic induction, satellite cells were plated as high density
micromass cultures in the presence of chondrogenic media:
DMEM (Invitrogen), supplemented with ITS (insulin, transferrin,
selenate, Sigma Cat#12521), 0.1 mM ascorbic acid (Sigma, MO),
human serum albumin (HSA, Sigma), 10
27 M dexamethasone,
and 10 ng/ml TGFß3 (R&D, MN) or BMP2 (R&D)) [23–24].
Briefly, cells were split and resuspended as 10
5 cells/10 ml droplet,
and pipetted onto a plate and allowed to adhere in a 37uC, 5%
CO2 incubator for approximately one hour before the addition of
chondrogenic media. All cells were grown for 5 days before they
were subject to histological and qRT-PCR analysis.
Virus production and infection of satellite cells
Avian-specific retroviruses (RCAS) were generated by first
transfecting chick embryonic fibroblasts (CEF) with retroviral
constructs encoding for the following genes: GFP, Nkx3.2HA,
Sox9V5, Alkaline phosphatase (AP), Pax3HA, Nkx3.2DC-HA
(deletion of C-terminus from aa219–278), or Nkx3.2DC-VP16
[25,26,27]. The viral supernatant was concentrated by ultracen-
trifugation (21,000 rpm, 2 hrs), and titered by directly visualizing
GFP expression (in the case of RCAS-GFP) or indirect immuno-
cytochemistry using anti-GAG antibody (which recognizes the
viral coat protein GAG). Viruses with titers of at least 10
8
particles/ml were used in all satellite cell cultures. For co-infection
experiments, viruses of different coat proteins A- or B- were used.
Retroviral infection of satellite cells was carried out by directly
adding concentrated virus into growing cell cultures. High levels of
expression were detectable 48 hrs post-infection, at which time the
cells were split and used in subsequent experiments.
Luciferase Assays
For the construction of the luciferase construct, a published
murine Pax3 promoter sequence (1.5 kb) [28] was cloned into
SmaI and NheI sites of the pGL3 luciferase vector (Promega,
Wisconsin). Satellite cells were transfected with pGL3-Pax3
promoter construct or pGL3 control using Fugene6 according to
the manufacturer’s protocol. After 48 hrs, cells were processed
using the Luciferase Assay System (Promega, Wisconsin). Briefly,
cells were thoroughly lysed with lysis buffer using a freeze-thaw
cycle. Supernatants were added to the luciferase assay reagent in a
96 well plate, then immediately read on a 1450 Microbeta Wallac
Trilux plate reading luminescence counter (Perkin Elmer, MA). At
least three independent experiments were performed to obtain
reproducible results.
Histological analyses
All samples were fixed with 4% paraformaldehyde (Sigma). For
alcian blue staining, cryosections of satellite cell micromass
cultures were pre-washed with 0.1 N HCl then incubated with
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washes with 0.1 N HCl. Hematoxylin and eosin (H&E) (Sigma)
staining was carried out according to standard protocol on
cryosectioned mouse tissues. Staining for heat-inactivated alkaline
phosphatase (HI-AP) on serial cryosectioned mouse tissue was
achieved by incubating the slides at 75uC for 50 min, to eliminate
endogenous AP activity, followed by application of NBT (100 mg/
ml in 70% dimethyl formamide) and BCIP (50 mg/ml in dimethyl
formamide) (Invitrogen, CA).
For immunocytochemistry, the following primary antibodies
were used: mouse anti-Collagen II (generous gift from Dr. Tom
Linsenmayer, Tufts University), rabbit anti-Collagen II (Abcam,
MA), rabbit anti-Sox9 (Chemicon, MA), mouse anti-Pax3
(Developmental Studies Hybridoma Bank (DSHB), IA), mouse
anti-Pax7 (DSHB), mouse anti-Myosin Heavy Chain (MHC)
(MF20 from DSHB), rabbit anti-HA (Sigma), rabbit anti-V5
(Sigma), rabbit anti-VP16 (Abcam), mouse anti-CD34 (AbD
Serotec), mouse anti-CD45 (AbD Serotec), mouse anti-M-
cadherin (BD Transduction Laboratories), rabbit anti-Myf5 (Santa
Cruz), rabbit anti-Desmin (Abcam), and rat anti-Sca-1 (AbD
Serotec). For immunohistochemistry of mouse tissues, cryosections
were first subject to antigen retrieval by treating slides with 1%
sodium dodecyl sulfate (SDS) in phosphate-buffered saline (PBS)
for 5 min at room temperature prior to subsequent staining steps.
For all other immunocytochemistry of cell culture, no antigen
retrieval was used. All samples were first blocked with PBS with
0.1% Triton X-100 (Sigma) and 6% goat serum (Sigma), then
incubated with primary antibodies overnight. After repeated
washes with PBS with 0.1% Tween (PBST), cultures were
incubated with secondary antibodies. For immunofluorescent
staining, all secondary antibodies used were conjugated with
Alexa 488 (green) or 594 (red) (Invitrogen, CA), and all cultures
were counterstained with DAPI (Invitrogen, CA). For colorimetric
immunostaining, the secondary antibody (Vector Laboratories,
CA) was conjugated with biotin, and the signal was amplified using
the Vectastain Elite ABC kit (Vector Laboratories, CA) and
developed using DAB-peroxidase (Sigma).
Reverse Transcriptase-Polymerase Chain Reaction (RT-
PCR) Analysis
RNA was isolated from all cell cultures using the RNeasy mini-
kit from Qiagen (Chatsworth, CA). For RNA samples isolated
from mouse tissue cryosections using laser capture microscopy
(LCM), Qiagen MicroKit was used (Chatsworth, CA). cDNA was
generated using MLV-reverse transcriptase (Invitrogen, CA)
according to standard protocol. All quantitative PCRs were
performed on the iQ5 Real-Time PCR Detection System
(BioRad, Hercules, CA). At least three independent experiments
were performed to obtain reproducible results.
All PCR analyses of in vitro experiments were normalized to
GAPDH. All PCR analyses from in vivo mouse LCM samples were
normalized to the 18S RNA. Sequences for all primers are listed in
‘‘Supporting information’’, Table S1. All PCR primers were
designed to amplify 100–200 bp of each gene for compliance with
the requirement of the real time PCR machine.
Western Blot analysis
For Western Blot analysis, total protein lysates were obtained
following a standard protocol from confluent 6 cm tissue culture
plates containing roughly 3610
6 cells [25]. The proteins were
separated by SDS-PAGE using BioRad mini-gel apparatus and
blotted onto nitrocellulose membranes using BioRad transfer
apparatus. The membranes were blotted with the following
antibodies overnight: rabbit anti-Collagen II (Abcam) and mouse
anti-ß-actin (Abcam). After repeated washing, the membranes
were hybridized with secondary antibodies of goat anti-mouse or
goat anti-rabbit HRP conjugated antibodies (Calbiochem). The
signals were developed using Pierce ECL substrate (cat# 32106),
and Kodak films exposed to chemiluminescent signals were
developed in Kodak M35A X-OMAT processor.
Glycosaminoglycan (GAG) assay
Virus-infected muscle satellite cells were seeded into silk porous
scaffold discs (5 mm in diameter, 3 mm in height, pore size: 500–
600 mm, a generous gift from Dr. David Kaplan, Tufts University)
at 10
5 cells/scaffold [29] and cultured for 7 days. Silk scaffolds
were digested overnight using a standard papain digestion cocktail
(125 mg/mL papain, 5 mM L-cysteine, 100 mM Na2HPO4, and
5 mM EDTA, pH 6.2) at 60uC. For total glycosaminoglycan
(GAG) analysis, 1,9-dimethylmethylene blue (DMMB) assay was
used [30]. Briefly, the papain-digested samples were mixed with
DMMB reagent and absorbance was measured at 525 nm. GAG
was estimated using a standard curve generated using shark
chondroitin sulfate (Sigma).
Culturing chondrogenic cells in the living bone
To create the culture environment for long bone growth,
fertilized chicken eggs were incubated for 3 days, at which time a
small window was created in the egg shell to expose the
chorioallantoic membrane (CAM), which is rich in blood supply
[31,32,33]. Mouse humeri along with the surrounding muscle and
connective tissues were isolated from postnatal day 7 mice (C57B6
strain). Virus-infected muscle satellite cells were seeded into silk
porous scaffold discs (2 mm in diameter, 2 mm in height, pore
size: 500–600 mm, a generous gift from Dr. David Kaplan) at 10
4
cells/scaffold [29]. To implant the satellite cell constructs, the skin
and fascia were first carefully retracted to expose the underlying
bone, and an incision was made. The cell/scaffold construct was
then placed between the bone segments, and secured in place
using a 30G syringe needle. The skin and fascia were then pulled
back over the resected bone, and the entire limb was placed on top
of the CAM. Finally, the window of the egg shell was sealed with
plastic tape, and the egg was placed in a humidified 37uC
incubator for 7 days before histological analysis.
Microscopy
Bright-field and fluorescent images from histological and
immunocytochemistry analyses were taken under the Olympus
IX71 inverted microscope using Olympus DP70 digital camera
and associated software (Olympus, PA). Laser capture microscopy
(LCM) was performed using the Arcturus PixCell IIe system (Tufts
Imaging Facility, Center for Neuroscience Research) using the
established protocol [34,35]. Briefly, cryosectioned tissues were
dehydrated and were overlaid with a thermoplastic membrane,
which was mounted on an optically transparent cap (Arcturus
Macro LCM caps, Applied Biosystem, CA). Target tissues were
identified by comparisons with serial sections that were stained
with heat-inactivated alkaline phosphatase (HI-AP). Upon laser
activation, target cells were captured by focal melting of the
membrane, then the captured tissue was immersed in a
denaturation solution and was subsequently subject to RNA
isolation.
Fracture creation in MyoD-cre Z/AP labeled mice
MyoD-cre Z/AP reporter mice were bred by the crossing of the
MyoD-cre [4] and Z/AP [36] lines. The MyoD-Cre mouse line was
a gift from Dr. David Goldhamer (University of Connecticut,
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(Children’s Medical Research Institute, Westmead, NSW, Aus-
tralia) with permission from Prof. Andras Nagy (Samuel Lunenfeld
Research Institute, Toronto, Ontario, Canada). The cross strain
labels all MyoD(+) lineage cells to permanently express the heat-
resistant human placental alkaline phosphatase (hPLAP). Midshaft
tibial fractures were generated in anaesthetized 2–3 month old
MyoD-cre Z/AP mice and littermate controls by manual three-
point using a previously published model [13,37]. Tissue
specimens harvested from mice of 1 week post fracture were used
for enzymatic and immunohistochemical staining, as well as laser
capture microscopy (LCM) studies. Animal experimentation was
approved by the CHW/CMRI Animal Ethics Committee (K248)
and the Westmead Hospital Animal Ethics Committee (4102).
Statistical Analysis
For statistical analysis, the mean and standard deviation were
calculated and are shown in all figures. At least three independent
experiments were performed to obtain reproducible results, and at
least three independent samples or slides were analyzed in each
experiment. Statistically significant differences (i.e., p,0.05) were
determined by one-factor analysis of variance (ANOVA) with post
hoc Tukey test using the statistics software SYSTAT12 (Systat,
Chicago, IL, USA). Conclusions on alteration of gene expression
(such as upregulation and downregulation) were drawn based on
statistical analysis.
Results
Isolated muscle satellite cells can be differentiated into
chondrocytes at the expense of normal muscle cell
differentiation
For chondrogenic differentiation of myogenic cells, muscle
satellite cells were grown as micromass cultures in chondrogenic
medium. Satellite cells were isolated from the pectoralis muscles of
late stage chicken embryos, which give rise to muscle cells that are
phenotypically similar to those from adult muscle [38]. The
identity of muscle satellite cells was confirmed by immunocyto-
chemistry analysis, which indicated that our cells were $95%
positive for satellite cells markers Pax3, Pax7, M-cadherin and
CD34 at day 0 (D0) (Figure 1A) [39,40]. Some cells (33%) were
positive for Myf5 (Figure 1A), suggesting that some of the satellite
cells had become activated during the isolation [2]. As none of
these cells were positive for Desmin (Figure 1A) or myosin heavy
chain (MHC) (data not shown), it indicates that the muscle satellite
cells had not undergone myogenic differentiation [41]. We further
confirmed the identity of the satellite cells by evaluating the
expression of other lineage markers. We found that these satellite
cells did not express CD45 or Sca-1, thus we believe that they did
not contain hematopoietic stem cells or fibrocyte progenitors
[39,40]. Quantification of cell lineage markers is shown in
supplemental information (Figure S1). Furthermore, when these
cells were differentiated, nearly 100% of them were positive for
myogenic differentiation marker Desmin (Figure S1). We then
cultured the satellite cells in three-dimensional (3D) micromass
cultures in the presence of the standard chondrogenic media
containing TGFß3 [23,24]. This culture system has been
established to differentiate embryonic progenitor cells or bone
marrow-derived mesenchymal stem cells into cartilage cells
[23,24,42]. Indeed, our immunocytochemistry and RT-PCR
analyses indicated that upon treatment with chondrogenic
medium for 5 days, there was a dramatic reduction of Pax3 and
Pax7, as well as committed myoblast marker MyoD, and
differentiated myocyte marker myosin heavy chain (MHC)
(Figure 1C and 1D). Concurrently, culturing with chondrogenic
medium resulted in the induction of cartilage matrix, as shown by
immunocytochemistry analysis of cartilage marker collagen II
(Figure 1E), as well as alcian blue staining which reflects
glycosaminoglycan (GAG) content (Figure 1E) [43]. To determine
the efficiency of chondrogenesis, we dissociated the condensed
cells from micromass cultures and evaluated collagen II expression
by immunocytochemistry. We found that almost all cells treated
with the chondrogenic medium exhibited significantly higher
levels of collagen II (Figure S2). This was further confirmed by
qRT-PCR analysis, which showed that chondrogenic medium
treatment led to the induction of transcription factors Nkx3.2 and
Sox9, as well as cartilage matrix markers collagen II and aggrecan
(Figure 1F). Replacing TGFß with BMP2 in the chondrogenic
medium led to similar results (data not shown). We found that
satellite cells of a later passage (P2) had a reduced capacity for
chondrogenic differentiation (Figure S3), therefore we opted to use
passage 0 satellite cells for future experiments. Furthermore, in our
time course study, we found that while myogenic gene expression
(Pax3, Pax7 and MyoD) showed a marked decrease at day 5 and
continued into day 12 in cells cultured in chondrogenic medium,
chondrocyte markers Nkx3.2, Sox9 and aggrecan were signifi-
cantly increased in expression at day 5 (Figure S4). This suggests
that the transition from the myogenic fate to chondrogenic fate
may have begun at day 5, which is the time point we opted to use
for subsequent experiments. Taken together, our data clearly
demonstrate that muscle satellite cells can be driven to adopt a
cartilage phenotype in vitro at the expense of the default muscle cell
fate.
Pax3 inhibits the adoption of cartilage cell fate by muscle
satellite cells
We next investigated the roles of intracellular factors on the
chondrogenic differentiation of satellite cells. Upon chondrogenic
differentiation of muscle satellite cells, muscle fate determining
factor Pax3 expression was strongly downregulated (Figure 1C and
1D). Therefore, we hypothesized that Pax3 would negatively
regulate the differentiation of satellite cells to chondrocytes. To test
this hypothesis, we infected muscle satellite cells with a Pax3HA-
encoding retrovirus, and cultured these cells in 3D micromass in
chondrogenic medium. We confirmed the ectopic expression of
Pax3 by qRT-PCR analysis (Figure 2A). Significantly, while
control virus-infected cells maintained a spherical appearance in
the course of micromass cultures, Pax3-infected cells showed a
much more elongated appearance (Figure S5), although we could
not clearly distinguish the differences in cell shape due to cell
condensation that accompanies chondrogenesis. At the gene
expression level, forced expression of Pax3 in chondrogenic
medium caused a significant decrease in expression of cartilage
markers collagen II and aggrecan as compared to controls
(Figure 2B and 2C), while leading to an increase in the expression
of muscle markers MyoD, myogenin, and MHC (Figure 2D). We
did not observe any differences in the expression levels of PPARc,
osteopontin or vimentin, suggesting that Pax3 may not have
promoted adipocyte, fibrocyte or bone lineages in the satellite cells
(Figure S6) [39,40]. Taken together, our results indicate that Pax3
inhibits chondrogenesis in muscle satellite cells, and suggest that
for muscle satellite cells to differentiate into chondrocytes, Pax3
expression must first be inhibited.
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muscle satellite cells
Next we assessed whether factors induced by chondrogenic
media were capable of inhibiting the default muscle fate of satellite
cells. Sox9 and Nkx3.2 are two factors induced by TGFß-
containing chondrogenic medium (Figure 1F), and have been
shown to promote cartilage formation during embryogenesis
[44,45,46,47,48,49]. However, it has not been determined
whether these factors might influence chondrogenic differentiation
of muscle satellite cells. Thus, we ectopically expressed retroviruses
encoding Nkx3.2HA and/or Sox9V5, whose expression levels
were confirmed by qRT-PCR (Figure S7). We found that forced
Figure 1. Isolated muscle satellite cells can be redirected toward a cartilage phenotype at the expense of the default muscle
phenotype. (A) Immunocytochemistry analysis indicating that isolated chicken muscle progenitor cells at day 0 are over 95% positive for Pax3, Pax7,
M-cadherin and CD34 (red staining). They are 33%-positive for Myf5 and are negative for Desmin, CD45 and Sca-1. Percentage positive cells=number
of positively stained cells/total cell number (based on DAPI staining). (B) Immunocytochemistry results indicating a dramatic downregulation of Pax3,
Pax7, and MHC in response to chondrogenic stimuli. (C) qRT-PCR analysis showing decreased expression of muscle markers Pax3, Pax7, MyoD, and
MHC in chondrogenic media as compared to those cultured in regular media. (D) Immunocytochemistry analysis on sectioned micromass cultures
showing increased collagen II protein expression upon chondrogenic media treatment. Alcian Blue staining indicates increased glycosaminoglycan
levels when cultured in chondrogenic media as compared to those cultured in regular media. (E) qRT-PCR analysis showing increased expression of
cartilage markers Nkx3.2, Sox9, collagen II, and aggrecan in chondrogenic media as compared to those cultured in regular media. All PCR results were
normalized to GAPDH. ‘‘*’’ denotes p,0.05 in statistical analysis.
doi:10.1371/journal.pone.0039642.g001
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strongly inhibited Pax3 expression, as Nkx3.2-expressing cells
expressed less Pax3 as confirmed by immunostaining (Figure 3A)
and qRT-PCR analysis (Figure 3B). Sox9, on the other hand, only
weakly inhibited Pax3 expression, suggesting that Nkx3.2 is a more
potent inhibitor of muscle cell fate in satellite cells (Figure 3A and
3B). Similarly, Nkx3.2 inhibited the expression of satellite cell
marker Pax7 as well as MHC, a marker for differentiated
myocytes (Figure 3C–3F). As these satellite cells were already
expressing a high level of Pax3 and Pax7 upon isolation, the
inhibition of Pax3 and Pax7 at the protein level was not as
dramatic as that of MHC (Figure 3). While the effect of Sox9 on
muscle gene expression was not clearly visible in the less
quantitative analysis of immunocytochemistry (Figure 3A, 3C
and 3E), RT-PCR analysis indicates that Sox9 consistently
exhibited a significant though weak inhibition of Pax3, Pax7 and
MHC expression relative to the inhibitory effect of Nkx3.2 on
muscle marker expression (Figure 3B, 3D and 3F). Combinatorial
treatment of Nkx3.2 and Sox9 led to inhibition of muscle cell fate
similar to that of Nkx3.2 alone, suggesting that there is no synergy
between these two factors and that they may not act independently
in this process (Figure 3). Together, these data demonstrate that
Nkx3.2, and to a much lesser extent, Sox9, are cartilage-associated
transcription factors that can prevent satellite cells from adopting
their default muscle fate.
The C-terminus of Nkx3.2 is required for the inhibition of
muscle cell fate in muscle satellite cells
Given that Nkx3.2 strongly inhibited the muscle fate in satellite
cells, we next determined if this effect was specific by using two
Nkx3.2 mutants. In the Nkx3.2-DC mutant, 58 amino acids from
the C-terminus were deleted. During somite differentiation in the
embryo, Nkx3.2 was found to behave as a transcriptional repressor
and the C-terminus was determined to be transcriptional
repression domain for promoting cartilage formation [49]
[26,50]. However, it is not clear whether this domain is also
required for inhibiting muscle cell fate in satellite cells. The other
mutant we used was a reverse function mutant of Nkx3.2 whose C-
terminus domain had been replaced by a VP16 constitutive
activation domain (Nkx3.2DC-VP16). We found that while wild
type Nkx3.2 infection led to a significantly reduced Pax3, Pax7
and MHC expression in satellite cells, Nkx3.2-C-terminus deletion
mutant (Nkx3.2-DC-HA) did not inhibit the expression of Pax3 at
the protein or mRNA level (Figure 4A and 4B). Significantly,
Nkx3.2DC-VP16 induced the expression of Pax3 (Figure 4B).
Nkx3.2 fusion with the VP16 activation domain led to the opposite
phenotype as wild type Nkx3.2, suggesting that Nkx3.2 acts as a
transcriptional repressor in inhibiting Pax3 expression. Similar to
the effect on Pax3 expression, Nkx3.2-DC mutant did not inhibit
Pax7 expression (Fig. 4C and 4D), suggesting that the C-terminus
of Nkx3.2 is required for Pax7 repression as well. Interestingly,
Figure 2. Viral infection with Pax3 in muscle satellite cells inhibits chondrogenesis while maintaining muscle gene expression. qRT-
PCR analysis of satellite cells infected with RCAS-A-Pax3 or RCAS-A-AP (alkaline phosphatase, control virus) and cultured in 3D micromasses in
chondrogenic media. (A) Pax3 mRNA, (B) Collagen II mRNA, (C) Aggrecan mRNA, and (D) MyoD, Myogenin, MHC mRNA expression. All PCR results
were normalized to GAPDH. ‘‘*’’ denotes p,0.05 in statistical analysis.
doi:10.1371/journal.pone.0039642.g002
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completely abolish Nkx3.2-mediated MHC repression (Figure 4E
and 4F), suggesting Nkx3.2 may inhibit MHC expression through
additional domains other than the C-terminus. While replacing
the C-terminus with a VP16 activation domain led to significantly
enhanced expression of Pax3 and MHC, it did not lead to
increased Pax7 expression in the satellite cells (Figure 4B, 4D and
4F). The effect of Nkx3.2DC-VP16 on Pax7 expression could be
due to the intricate interaction of Pax7 with other myogenic
factors, such as Pax3 and myogenin, which were both shown to
inhibit Pax7 expression [51,52].
Figure 3. Nkx3.2 and Sox9 inhibit muscle-specific gene expression in muscle satellite cells. Muscle satellite cells were infected with RCAS
viruses encoding GFP, Nkx3.2HA, Sox9V5 or Nkx3.2HA+Sox9V5. Immunocytochemistry and qRT-PCR analyses were performed. Virus staining images
were overlaid with Pax3, Pax7 and MHC images, and DAPI stains cell nuclei. For all qRT-PCR, GAPDH was used for normalization. (A) Pax3
immunostaining results. (B) Pax3 mRNA expression. (C) Pax7 immunostaining results. (D) Pax7 mRNA expression. (E) MHC immunostaining results. (F)
MHC mRNA expression. ‘‘*’’ denotes statistically significant differences (p,0.05) relative to control samples.
doi:10.1371/journal.pone.0039642.g003
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Since Nkx3.2 acts as a repressor to strongly inhibit Pax3
expression, we hypothesized that Nkx3.2 may inhibit Pax3 at the
promoter level. A mouse Pax3 promoter sequence was previously
identified from LacZ reporter analysis in transgenic mice which
indicated that this promoter recapitulates endogenous Pax3
expression in the trunk [28]. Thus, we generated a luciferase
reporter that contains this murine Pax3 promoter sequence to
Figure 4. The C-terminus of Nkx3.2 is required to inhibit muscle cell fate in muscle satellite cells. Muscle satellite cells were infected with
RCAS viruses encoding GFP, Nkx3.2HA, Nkx3.2-DCHA or Nkx3.2-DC-VP16. Immunocytochemistry and qRT-PCR analyses were performed. Virus
staining images were overlaid with Pax3, Pax7 and MHC images, and DAPI stains cell nuclei. For all qRT-PCR, GAPDH was used for normalization. (A)
Pax3 immunostaining results. (B) Pax3 mRNA expression. (C) Pax7 immunostaining results. (D) Pax7 mRNA expression. (E) MHC immunostaining
results. (F) MHC mRNA expression. ‘‘*’’ denotes statistically significant differences (p,0.05) relative to control samples.
doi:10.1371/journal.pone.0039642.g004
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inhibit its expression (Figure 5A). For comparison, we also
evaluated the effect of GFP and Sox9 on the Pax3 promoter.
We first infected satellite cells with retroviruses that express GFP,
Sox9V5, Nkx3.2-HA, Nkx3.2DC-HA, or Nkx3.2DC-VP16, and
confirmed the efficiency of viral infection by performing immu-
nocytochemistry (Figure 5B). We then transfected the Pax3
promoter luciferase construct into these satellite cells. We found
that while Sox9 showed a moderate but significant reduction in
Pax3 promoter activity, Nkx3.2 dramatically inhibited Pax3
promoter activity (Figure 5C). C-terminal deletion mutant of
Nkx3.2 (Nkx3.2-DC) showed essentially no effect on the Pax3
promoter as compared to control GFP-infected cells (Figure 5B).
Intriguingly, the Nkx3.2 reverse function mutant (Nkx3.2-DC-
VP16) activated the Pax3 promoter by two folds (Figure 5C).
Although it is unclear at this moment whether Sox9 and Nkx3.2
exert their effect on the Pax3 promoter through direct binding, our
promoter study results are consistent with our analyses of
endogenous Pax3 mRNA and protein expression in satellite cells,
and lead us to conclude that Nkx3.2 and Sox9 may inhibit muscle
gene expression by inhibiting the Pax3 promoter.
Treatment with either Nkx3.2 or Sox9 can induce
cartilage gene expression in muscle satellite cells
As the differentiation of muscle satellite cells into chondrocytes
involves not only the repression of muscle cell fate but also the
initiation of chondrogenesis, we next examined the roles of Nkx3.2
and Sox9 in the induction of cartilage genes in muscle satellite
cells. We tested if either of these factors could induce chondro-
genesis by infecting the satellite cells with viruses expressing Sox9
and/or Nkx3.2. Immunostaining results indicated that either
Nkx3.2 or Sox9 infection alone could induce cartilage marker
collagen II expression, and that the combination of these two
factors had an additive effect, showing a more intense collagen II
staining upon Nkx3.2 and Sox9 co-infection (Figure 6A). The
protein expression of collagen II was further confirmed by Western
blot analysis (Figure 6B). Additionally, qRT-PCR analysis
demonstrated that collagen II expression was also elevated at the
mRNA level (Figure 6C). To ascertain whether Nkx3.2 and Sox9-
infected cells can maintain their chondrocyte phenotype in vivo,w e
implanted the cells into the mouse bone. Under established
protocol, mouse humeri were cultured on the chicken chorioal-
lantoic membrane (CAM), which provides nutrient and blood
supply to the cultured tissues [31,32,33]. We found that Nkx3.2
and Sox9-infected cells maintained collagen II expression (Figure
S8).
Interestingly, while Sox9 alone could induce aggrecan expres-
sion, Nkx3.2 alone could not (Figure 6C), even in longer-term
cultures (Figure S9). However, when combined with Sox9, Nkx3.2
led to a synergistic induction of aggrecan expression (Figure 6D).
Thus it is possible that Nkx3.2 and Sox9 regulate the expression of
these two cartilage matrix components differently. Finally, we
performed a glycosaminoglycan (GAG) assay. This is an estab-
lished functional assay for differentiated chondrocytes, as cartilage
matrix proteoglycans, aggrecan in particular, bind to GAGs (such
as heparin sulfate), whose negative charges allow cartilage to resist
compression [53,54,55]. We found that total GAG content in the
satellite cells was significantly induced by Sox9 as well as Nkx3.2/
Sox9 co-infection, which is consistent with the qRT-PCR analysis
for aggrecan (Figure 6E). Together, these data suggest that Nkx3.2
and Sox9 promote chondrogenic differentiation of muscle satellite
cells.
A reverse function mutant of Nkx3.2 blocks the ability of
Sox9 to induce chondrogenesis and inhibit myogenesis
in muscle satellite cells
Since both Nkx3.2 and Sox9 can promote the chondrogenic
differentiation of satellite cells, we investigated the relationship
between these factors. We found that indeed, Nkx3.2 and Sox9
induced each other’s expression in satellite cells (Figure 7A and
7B). Sox9 is known to strongly induce chondrogenesis by directly
activating the promoters of cartilage matrix genes [45,56,57]. Our
data support this notion and further demonstrate that Sox9 has a
weak activity in inhibiting myogenesis. Because Nkx3.2 exerts a
stronger inhibitory activity on Pax3, the myogenic factor that can
inhibit chondrogenesis, we asked whether the activity of Sox9 on
chondrogenesis and myogenesis in satellite cells may be attributed
to the induction of Nkx3.2. Therefore, we made use of the reverse
function mutant of Nkx3.2 (Nkx3.2-DC-VP16), to evaluate
whether this mutant, acting in a dominant-negative manner,
would compromise the ability of Sox9 [27].
Strikingly, we found that while Sox9-treated satellite cells
dramatically upregulated collagen II expression, Nkx3.2DC-VP16
co-infection with Sox9 led to a dramatic reduction in this cartilage
matrix protein (Figure 7C). This is further confirmed by our RT-
PCR analysis that showed diminished expression of collagen II
mRNA as well as aggrecan mRNA upon Nkx3.2DC-VP16 and
Sox9 co-infection (Figure 7D and 7E). We next asked whether
Nkx3.2 is required for the weak inhibitory activity of Sox9 on
muscle gene expression. Indeed, we found that co-infection of
Nkx3.2DC-VP16 with Sox9 completely abolished the ability of
Sox9 to inhibit Pax3 and MHC expression (Figure 7F and 7G).
This suggests that Sox9 is unable to induce chondrogenesis in the
absence of the activity of Nkx3.2, and that Sox9 may inhibit the
myogenic program in the satellite cells through the induction of
Nkx3.2.
Nkx3.2 and Sox9 are induced in the muscle progenitor
cells that contribute to cartilage formation and fracture
repair in an in vivo mouse model of bone fracture
healing
To establish the in vivo significance of Nkx3.2 and Sox9 in the
chondrogenic differentiation of muscle satellite cells, we evaluated
the expression of these factors in the myogenic progenitor cells that
give rise to chondrocytes during the process of bone fracture
healing. The MyoD-cre: Z/AP mouse was generated by crossing
two transgenic lines as described in Materials and Methods
(Figure 8A). The MyoD-driven Cre mouse line allows Cre to be
expressed in all muscle progenitor cells, including satellite cells [4].
Upon Cre-mediated recombination, the Z/AP line permanently
expresses the human placental alkaline phosphatase (hPLAP)
reporter gene in affected cells (Figure 8A). The heat-stable
property of hPLAP enabled us to distinguish the expression of
this reporter from that of endogenous alkaline phosphatase, which
is abundantly expressed in bone cells [9,13]. Therefore, in this
MyoD-Cre+:Z/AP+ mouse, all satellite cells and their progenitors
express heat-stable alkaline phosphatase, which is marked by
purple staining from enzymatic reactions (Figure 8A). When the
MyoD-Cre+:Z/AP+ mouse was subject to open tibial midshaft
fractures, muscle progenitor cells or their descendants were
abundantly seen in the fracture callus region (Figure 8B). This
callus region is known to undergo cartilage and bone differenti-
ation during the process of fracture healing [58,59]. In addition to
contributing to the fracture callus, it is evident that hPLAP+ cells
also marked the muscle next to the bone, and did not mark any of
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the validity of this method.
To evaluate whether Sox9 and Nkx3.2 were induced in the
muscle progenitor cells, we performed immunohistochemistry
(IHC) on sections of the fracture region (Figure 8C). We found that
Sox9 was strongly expressed in the cells in the fracture callus,
which correlated with the induction of cartilage marker collagen II
expression (Figure 8C). Due to the lack of a suitable antibody
against Nkx3.2, we were unable to perform IHC to evaluate
Nkx3.2 protein expression. Thus, to evaluate Nkx3.2 expression
and to confirm that Nkx3.2 and Sox9 are indeed induced in the
muscle progenitor cells that give rise to chondrocytes in the
fracture healing process, we performed laser capture microscopy
(LCM). We captured hPLAP+ muscle progenitor cells from the
fracture callus region of frozen tissue sections using alkaline
phosphatase (hPLAP) staining on slides of serial sections as a
reference. We then compared the expression of muscle and
cartilage markers in these muscle progenitor cells from the fracture
callus to that of neighboring muscle tissue (Figure 8D). We found
that muscle progenitor cells in the fracture callus strongly
expressed Nkx3.2 and Sox9, as well as collagen II, as compared
with cells in the muscle (Figure 8D). In the meantime, these cells
downregulated the expression of muscle markers Pax3, Pax7 and
MHC (Figure 8D). These data thus suggest that Nkx3.2 and Sox9
are indeed expressed in the muscle progenitor cells that contribute
to cartilage formation during fracture healing, which is consistent
with the notion that they promote chondrogenic differentiation of
satellite cells.
Figure 5. Nkx3.2 and Sox9 inhibit mouse Pax3 promoter activity. (A) Schematic diagram of the mouse Pax3 promoter luciferase construct.
(B) Immunocytochemistry analysis showing equal infection efficiencies of all viruses (GFP, Sox9, Nkx3.2, Nkx3.2-DC-HA, Nkx3.2-DC-VP16). (C)
Luciferase analysis on satellite cells infected with all viruses (GFP, Sox9, Nkx3.2, Nkx3.2-DC-HA, Nkx3.2-DC-VP16) and transfected with the Pax3
luciferase construct. A control luciferase vector was used for normalization. ‘‘**’’ denotes p,0.01 and ‘‘***’’ denotes p,0.001 in statistical analysis.
doi:10.1371/journal.pone.0039642.g005
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In this work we show that the muscle satellite cells that normally
undergo myogenesis can be converted to express cartilage matrix
proteins in vitro upon treatment with chondrogenic medium
containing TGFß or BMP2. In the meantime, the myogenic
program is repressed, suggesting that muscle satellite cells have
undergone chondrogenic differentiation. Furthermore, we dem-
onstrate that muscle-determining factor Pax3 strongly inhibits
chondrogenesis in these cells, while Nkx3.2 and Sox9 act
downstream of TGFß or BMP to promote this cell fate transition.
Importantly, our data suggest that Nkx3.2 is required for Sox9 to
inhibit myogenesis and induce chondrogenesis. Finally, in the
muscle progenitor cells that give rise to chondrocytes in an in vivo
model of fracture healing, Nkx3.2 and Sox9 are significantly
upregulated while Pax3 is significantly downregulated. These
events correlated with the induction of cartilage matrix protein
collagen II in lineage-traced muscle progenitor cells, suggesting
that the balance of Pax3, Nkx3.2 and Sox9 may play an important
role in the cell fate switch from muscle to cartilage, which may be
important for fracture healing.
Multiple other progenitor cell populations are present in the
muscle that can be instructed to adopt alternative cell fates. While
muscle satellite cells reside underneath the basal lamina of the
Figure 6. Nkx3.2 and Sox9 can induce muscle satellite cells to express cartilage markers collagen II and aggrecan. Muscle satellite cells
were infected with RCAS viruses encoding GFP, Nkx3.2HA, Sox9V5 or Nkx3.2HA+Sox9V5. Immunocytochemistry and qRT-PCR analyses were
performed. For all qRT-PCR, GAPDH was used for normalization. (A) Immunocytochemistry analysis of collagen II protein expression in satellite cells.
Virus staining images were overlaid with collagen II images, and DAPI stains cell nuclei. (B) Western Blot analysis of collagen II protein expression in
satellite cells. ß-actin, internal control. (C) qRT-PCR analysis of collagen II mRNA and (D) Aggrecan mRNA expression. (E) Glycoaminoglycan (GAG)
assay. ‘‘*’’ denotes p,0.05 in statistical analysis.
doi:10.1371/journal.pone.0039642.g006
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identified in the interstitial spaces of the muscle fibers [39,40].
These cells do not express muscle satellite cell marker Pax7 or
SM/C-2.6, but are positive for Sca1, Tie-2 and PDGFR-1a
[39,40]. While this FAP population can give rise to adipocytes, it
cannot be induced to become myogenic or chondrogenic. On the
other hand, a Sca-1-negative (also lin-negative) population (i.e. the
double-negative (DN) population) in the muscle was found to be
capable of differentiating into cartilage and bone, but incapable of
differentiating into myocytes [39]. Another progenitor population
is the muscle-derived stem cell population (MDSC) [60,61]. Unlike
muscle satellite cells or the FAP population, these MDSCs reside
within the basal lamina [61]. MDSCs are also positive for Sca-1
and negative for Pax7, and have the ability to give rise to muscle,
cartilage or bone cells [61]. As our cells are positive for Pax3,
Pax7, CD34 and M-cadherin, and negative for CD45 and Sca-1,
we believe that the cells used in our experiments do not belong to
the above populations. However, it is plausible that similar
molecular mechanisms are involved in the chondrogenic differen-
tiation of FAP or MDSC cells.
It has been established by the Goldhamer laboratory that the
MyoD(+) progenitors permanently label muscle satellite cells as
well as their derivatives in the mature muscle fibers [4]. While
Goldhamer and colleagues showed that these muscle progenitor
cells did not give rise to non-myogenic adipocytes [62], it was not
clear whether they have the capacity to adopt a chondrogenic or
osteogenic fate. In our study, we evaluated the expression of
Nkx3.2, Sox9 and Pax3 in the muscle progenitors that contribute
to cartilage formation during bone healing during fracture repair.
We demonstrate that muscle progenitor cells adopt a cartilage cell
fate upon chondrogenic stimulation in vitro, as well as during open
fracture healing in vivo. However, we did not distinguish which
specific subpopulations of satellite cells are more likely to undergo
chondrogenesis [2]. In vitro expansion of stem-like cells often results
in a loss of ‘‘stemness’’ as well as proliferative capacity [63]. It was
reported that muscle progenitor cells have decreased proliferation
and myogenic potential upon passaging, which is correlated with
increased senescence [64,65]. Interestingly, while muscle satellite
cells have an increased tendency to adopt a fibrocyte fate during
aging [66], our data showed that they have a reduced capacity to
become chondrogenic when passaged. It is possible that cellular
Figure 7. Nkx3.2 is required for Sox9 to activate a cartilage program and to inhibit the muscle program in muscle satellite cells. For
all qRT-PCR, GAPDH was used for normalization. (A) qRT-PCR analysis of Nkx3.2 expression in satellite cells infected with control RCAS-GFP virus or
RCAS-Sox9V5 virus. (B) qRT-PCR analysis of Sox9 expression in satellite cells infected with control RCAS-GFP virus or RCAS-Nkx3.2HA virus. (C)–(G)
Muscle satellite cells were co-infected with the following combination of viruses: RCAS-A-GFP+RCAS-B-AP (alkaline phosphatase); RCAS-A-AP+RCAS-
B-Sox9V5; RCAS-A-Nkx3.2HA+RCAS-B-Sox9V5; RCAS-A-Nkx3.2-DC-VP16+RCAS-B-Sox9V5. These infected cells were subject to immunocytochemistry
analysis and qRT-PCR. (C) Immunocytochemistry analysis of Collagen II protein expression in satellite cells. Virus staining images were overlaid with
Collagen II images, and DAPI stains cell nuclei. (D) Collagen II mRNA expression. (E). Aggrecan mRNA expression. (F). Pax3 mRNA expression. (G). MHC
mRNA expression. In A–B, ‘‘*’’ denotes p,0.05 in statistical analysis. In D–G, ‘‘*’’ denotes statistically significant differences (p,0.05) between RCAS-A-
AP+RCAS-B-Sox9V5 and RCAS-A-Nkx3.2-DC-VP16+RCAS-B-Sox9V5 co-infected samples.
doi:10.1371/journal.pone.0039642.g007
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prolonged monolayer culture of these cells could potentially hinder
their ability to form the 3D condensations required for chondro-
genesis [67]. We do not know whether these muscle progenitor
cells have undergone de-differentiation/re-differentiation or bona
fide transdifferentiation in our in vitro cell culture or in vivo fracture
healing models. While there was a significant amount of Pax3 and
Pax7 protein expression at the beginning of culturing, Pax3 and
Pax7 became gradually diminished upon Nkx3.2 and Sox9 viral
infection, concurrently with the induction of cartilage genes, which
should be consistent with a transdifferentiation process. Msx1 is
correlated with muscle cell dedifferentiation [68,69]. However,
msx1 is also highly expressed in chondrocytes and is induced by
BMP/TGFß signaling. Thus, although we observed a significant
induction of msx1 expression upon chondrogenic differentiation in
the satellite cells (data not shown), it does not indicate whether the
satellite cells have undergone dedifferentiation. Regardless, our
data support that muscle progenitor cells that normally would
undergo myogenesis, can be redirected to adopt a cartilage cell
fate in vitro and in vivo.
In this study, we have evaluated cartilage gene expression in the
muscle progenitor cells that contribute to fracture healing [70].
However, other cell types located in the vicinity of bone may also
participate in cartilage and bone formation. Elegant grafting
experiments using LacZ-positive donor mice and Lac-Z-negative
recipients revealed that cells from the perichondrium, the fibrous
covering of the bone, differentiate into chondrocytes and
osteocytes during fracture repair [71]. Cells associated with blood
vessels, such as pericytes, have also been shown to have the ability
to differentiate into chondrocytes [72]. Cells that are positive for
Tie-2, an endothelial cell marker, while not yet shown to be
recruited to the fracture callus, are known to contribute to
cartilage and bone formation during heterotopic ossification
[73,74]. Because of the diverse cell types that participate in
cartilage formation during fracture healing, it is likely that these
different types of cells use different signaling mechanisms when
undergoing chondrogenic differentiation. It is known that TGFß,
BMP, PTH, as well as Wnt signaling are all activated during
fracture healing, and downstream molecules such as Smad,
prostaglandin, Cox-2 and ß-catenin regulate this process
Figure 8. Nkx3.2 and Sox9 are induced in the muscle progenitor cells that contribute to cartilage formation in an in vivo mouse
model of fracture healing. (A) Schematic diagram illustrating the generation of the transgenic mice in which MyoD+ lineage cells are labeled with
heat-resistant alkaline phosphatase (hPLAP). (B) H&E histological analysis showing the fracture callus site 1 week post-fracture. Muscle progenitor cells
were identified by assaying for heat-resistant alkaline phosphatase (arrow). Left panels, low magnification (46); right panels, high magnification of the
boxed areas from the left panels (106). B, bone. C, callus, M, muscle. (C) Immunohistochemistry analyses of collagen II and Sox9 expression in the
fracture callus. DAPI staining images were overlaid with collagen II and Sox9 staining images. (D) Laser Capture Microscopy (LCM) analysis of muscle
progenitor cells in the fracture callus and in the neighboring muscle. qRT-PCR analyses were performed for the following genes: Nkx3.2, Sox9,
collagen II, Pax3, Pax7 and MHC. For all qRT-PCR, 18S RNA was used for normalization. ‘‘*’’ denotes p,0.05 in statistical analysis.
doi:10.1371/journal.pone.0039642.g008
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that transcription factors Pax3, Nkx3.2 and Sox9 regulate
chondrogenic differentiation of muscle progenitor cells. However,
it is unclear whether Nkx3.2 and Sox9 also participate in the
chondrogenic differentiation of other cell types, such as perichon-
drial or endothelial cells, and how these different cell types
coordinate their signaling events during fracture healing. The
understanding of such signaling processes in different cell types
may help to accelerate fracture healing.
Pax3, Nkx3.2 and Sox9 are all known to play important roles
during development. In embryogenesis, Pax3 is expressed in the
dermomyotome of the somite, which gives rise to muscle cell
precursors [41]. Pax3 mutant mice exhibit somite truncations with
loss of hypaxial dermomyotome, and absence of limb muscle [3].
Our data support the role of Pax3 in promoting myogenesis in
muscle satellite cells [85]. Furthermore, our data shows that Pax3
has an additional function of inhibiting chondrogenic differenti-
ation of muscle satellite cells. It was reported that constitutive
expression of Pax3 led to increased proliferation and decreased cell
size in satellite cells [86]. We found that Pax3-infected cells had a
much more elongated appearance as compared to the control cells
cultured in the chondrogenic medium, although we could not
clearly distinguish the differences in cell shape due to cell
condensation that accompanies chondrogenesis. In the double
knockout of Pax3 and its paralogue Pax7, significant cell death
takes place, leading to the loss of most muscle fibers [3]. In
addition, Pax3 and Pax7 double mutant cells were found in the
forming rib [3], suggesting that they may have adopted a cartilage
fate, a result consistent with our findings [25,87]. While Pax3 acts
as a transcriptional activator to promote myogenesis [88], it also
has a transcriptional repressor domain that is important for the
development of melanocytes [89,90,91,92,93]. It will be of interest
to determine whether Pax3 inhibits chondrogenesis by acting as a
transcriptional repressor or activator in the satellite cells. It will be
also of interest to investigate whether other myogenic factors play
inhibitory roles in chondrogenic differentiation.
We also discovered a novel function for Sox9 in this study. Sox9
is the master regulator of chondrogenesis, as no cartilage
formation takes place in the absence of Sox9 [46]. Sox9 acts as
a transcriptional activator in chondrogenic precursor cells by
binding to the promoters of cartilage-specific matrix genes
collagen II and aggrecan [45,56,57]. We found that Sox9 strongly
induced collagen II and aggrecan expression, as well as
glycosaminoglycan (GAG) level in the muscle satellite cells, which
normally are non-chondrogenic precursors, consistent with its
activity in the somite [25]. In the meantime, Sox9 also
significantly, although weakly, inhibited the expression of early
muscle lineage marker Pax3 and Pax7, as well as myosin heavy
chain (MHC). It has been reported that Sox9 is expressed in the
satellite cells, and has the ability to inhibit a-sarcoglycan
expression in the C2C12 myoblast cell line [94] and the myogenin
promoter in 10T1/2 cells [95]. Our data are consistent with these
reports. While Sox9 may be expressed in satellite cells, it is
apparent from our work and others that Sox9 is much more
strongly expressed in chondrocytes, and that ectopic expression of
Sox9 leads to chondrogenic differentiation and maintenance of the
chondrocyte phenotype [96,97].
Our data suggest that Nkx3.2 plays a central role in the
chondrogenic differentiation of satellite cells, and that its activity is
required for Sox9 to promote chondrogenesis and inhibit
myogenesis. Like Sox9, Nkx3.2 is expressed in the cartilage
precursors in the embryo, and promotes cartilage cell fate in the
somites [25,26]. Nkx3.2 null mice exhibit reduced cartilage
formation including a downregulation of Sox9 expression
[48,98,99]. Inactivating mutations of Nkx3.2 in human lead to
spondylo-megaepiphyseal-metaphyseal dysplasia (SMMD), a dis-
ease that causes abnormalities of the vertebral bodies, limbs and
joints [100]. Here we show that Nkx3.2 is activated in the muscle
satellite cells during chondrogenic differentiation in vitro as well as
in the adult fracture healing process in vivo, suggesting that Nkx3.2
may also be involved in a cell fate determination process at a stage
later than early embryogenesis. Furthermore, we show that
Nkx3.2 acts as a transcriptional repressor to inhibit Pax3 promoter
activity. While there are consensus Nkx3.2 binding sites on the
Pax3 promoter, we have not determined whether Nkx3.2 binds to
the Pax3 promoter [28]. Interestingly, Nkx3.2 has also been shown
to act as a repressor to inhibit osteogenic determining factor
Runx2, suggesting that Nkx3.2 may be used to inhibit other non-
cartilage cell fates [101]. We have also uncovered a pivotal role for
Nkx3.2 in the induction of chondrogenic genes. We found that
without the repressing activity of Nkx3.2, Sox9, despite its ability
to bind to collagen II and aggrecan promoters, was unable to
activate those genes or inhibit myogenesis. Additionally, Nkx3.2
potentiates the ability of Sox9 to induce aggrecan expression,
which may be due to its repression of chondrogenic inhibitor Pax3.
This data is consistent with the time course experiment (Figure
S4), which indicated that the high level expression of collagen II
and aggrecan is clearly correlated with the induction of Nkx3.2, as
Sox9 expression is reduced at later stages of chondrogenesis. In all,
our findings indicate that the intricate balance of Pax3, Nkx3.2
and Sox9 controls the determination of cartilage and muscle cell
fate in muscle satellite cells, and may play important roles in
regulating the process of fracture healing. As these factors are also
involved in early embryonic cell fate determination, our work
supports the notion that healing recapitulates development.
Understanding these signaling events may eventually allow us to
harness these mechanisms of chondrogenic differentiation to
enhance fracture healing.
Supporting Information
Figure S1 Quantitative characterization of muscle sat-
ellite cells. A. Percentage of cells positive for Pax3 (96%), Pax7
(95%), M-cadherin (97%), CD34 (98%), Myf5 (33%), Desmin
(1%), CD45 (1%), Sca-1 (0%). B. qRT-PCR analysis showing
satellite cells express high levels of Pax3 and Pax7 mRNA as
compared to chick fibroblasts (CEF). C. Isolated satellite cells were
able to differentiate into myoblasts and myocytes. Immunocyto-
chemistry analysis shows that after 8 days of culture, nearly all cells
express myoblast and myocyte markers Desmin. Some cells have
already fused and become MHC-positive, and expressed a much
higher level of Desmin than myoblasts.
(TIF)
Figure S2 Efficiency of satellite cell chondrogenesis.
Micromass cultures were dissociated in order to investigate the
percentage of cells that were positive for cartilage marker collagen
II by immunocytochemistry. A. Immunocytochemistry images
showing that cells in the control micromass cultures often showed
a more elongated nuclei, and had very little collagen II protein
expression. In contrast, cells in the micromass cultured in
chondrogenic medium had larger and rounder-shaped nuclei,
and the majority of them had significant collagen II staining
(arrows). B. Quantification of collagen II-positive cells. ‘‘*’’
denotes p,0.05 in statistical analysis.
(TIF)
Figure S3 Chondrogenic potential of satellite cells. A.
Pax3 and Pax7 expression is reduced in satellite cells of a later
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PLoS ONE | www.plosone.org 14 July 2012 | Volume 7 | Issue 7 | e39642passage (P2) as compared with freshly isolated cells (P0). B.
Chondrogenic potential of satellite cells of P0 and P2 passages.
When satellite cells were cultured as micromasses in chondrogenic
medium, P2 satellite cells showed a much reduced potential to
express cartilage marker aggrecan, but did not show any
differences in collagen II expression. ‘‘*’’ denotes p,0.05 in
statistical analysis.
(TIF)
Figure S4 A time course of chondrogenic differentiation
of muscle satellite cells. Muscle satellite cells were subject to
chondrogenic differentiation in micromass cultures, and their gene
expression was assayed at day 2, 5 and 12. A. Pax3, Pax7 and
MyoD expression was significantly reduced in satellite cells
cultured in chondrogenic medium over the course of 12 days.
B. Nkx3.2 expression was significantly increased in satellite cells
cultured in chondrogenic medium over the course of 12 days.
However, Sox9 expression became reduced by day 12. Aggrecan
expression reached a plateau at day 5. Interestingly, we did not
detect any significant increase in collagen II expression until day
12. ‘‘*’’ denotes p,0.05 in statistical analysis, when D5 and D12
expression was compared with that of D2.
(TIF)
Figure S5 Pax3 infection in muscle satellite cells causes
a flattened appearance in micromass cultures. Muscle
satellite cells infected with retrovirus GFP (control) or Pax3 were
cultured in chondrogenic media as micromasses for 5 days, then
cryosectioned and stained with H&E. Micromass cultures of Pax3-
infected cells (B) showed an elongated and flattened appearance as
to the spherical appearance of control cultures (A). As cells need to
be condensed for chondrogenesis to take place, it is difficult to
discern the cell shape within these micromass cultures.
(TIF)
Figure S6 Evaluation of other lineage markers upon
Pax3 infection in muscle satellite cells. Muscle satellite cells
infected with retrovirus GFP (control) or Pax3 were cultured in
chondrogenic media as micromasses for 5 days. Pax3 did not
significantly alter the expression of adipocyte marker PPARc,
bone marker osteopontin, or fibrocyte marker vimentin.
(TIF)
Figure S7 Nkx3.2HA and Sox9V5 are expressed at the
mRNA level in Nkx3.2HA and Sox9V5-infected cells.
qRT-PCR showing viruses encoding Nkx3.2HA and Sox9V5 led
to the expression of Nkx3.2HA and Sox9V5 expression. ‘‘*’’
denotes statistically significant differences (p,0.05) relative to
control samples.
(TIF)
Figure S8 Nkx3.2HA and Sox9V5-infected satellite cells
maintain collagen II expression in ovo. Nkx3.2HA and
Sox9V5-infected satellite cells were seeded into a 3D scaffold (silk-
derived) and implanted into a mouse bone (humerus, fractured for
cell implantation), and allowed to grow for 7 days in vivo on the
chicken chorioallantoic membrane (CAM). As mouse cells cannot
be infected by avian retroviruses, they can be distinguished from
implanted chicken satellite cells. A. Image of the mouse bone
cultured on top of the CAM inside the egg shell. B. Bright field
image of the bone. Dotted line highlights the outline of the
sectioned bone and implanted construct. Boxed area denotes the
location where cells were implanted. C. Immunostaining images
of chicken satellite cells. Implanted Sox9V5-positive cells
expressed collagen II (arrows). Additional collagen II staining
may come from host cells.
(TIF)
Figure S9 Nkx3.2 does not induce aggrecan expression
in long-term cultures. Muscle satellite cells infected with
retrovirus GFP (control) or Nkx3.2 were cultured in chondrogenic
media as micromasses for 5 or 12 days. The expression levels of
aggrecan between GFP and Nkx3.2-infected samples at both time
points were not statistically significant. Nkx3.2 thus may require
additional factors to induce aggrecan expression.
(TIF)
Table S1 RT-PCR primer sequences.
(PDF)
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